Cargando…

Evaluating the Potential of T Cell Receptor Repertoires in Predicting the Prognosis of Resectable Non-Small Cell Lung Cancers

For resectable cancer patients, a method that could precisely predict the risk of postoperative recurrence would be crucial for guiding adjuvant treatment. Since T cell receptor (TCR) repertoires had been shown to be closely related to the dynamics of cancers, here we enrolled a cohort of patients t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Zhengbo, Chen, Xiangbin, Shi, Yi, Huang, Rongfang, Wang, Wenxian, Zhu, Kunshou, Lin, Shaofeng, Wang, Minxian, Tian, Geng, Yang, Jialiang, Chen, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488751/ https://www.ncbi.nlm.nih.gov/pubmed/32995352 http://dx.doi.org/10.1016/j.omtm.2020.05.020

Ejemplares similares

Treatment and Prognosis of Solid and Cystic Brain Metastases in Patients with Non-Small-Cell Lung Cancer
por: Xu, Yi-Bing, et al.
Publicado: (2021)

Baseline anemia and anemia grade are independent prognostic factors for stage IV non-small cell lung cancer
por: Chen, Cheng, et al.
Publicado: (2021)

Efficacy of brain radiotherapy plus EGFR-TKI for EGFR-mutated non-small cell lung cancer patients who develop brain metastasis
por: Wang, Wenxian, et al.
Publicado: (2018)

Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective study
por: Wei, Jingwen, et al.
Publicado: (2022)

RUNX3/H3K27me3 Co-Expression Defines a Better Prognosis in Surgically Resected Stage I and Postoperative Chemotherapy-Naive Non-Small-Cell Lung Cancer
por: Chen, Xiaohui, et al.
Publicado: (2022)

Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study
por: Wang, Wenxian, et al.
Publicado: (2022)

Gene Alterations in Paired Supernatants and Precipitates from Malignant Pleural Effusions of Non-Squamous Non-Small Cell Lung Cancer
por: Li, Jianqiang, et al.
Publicado: (2020)

Combination of albumin concentration and neutrophil-to-lymphocyte ratio for predicting overall survival of patients with non-small cell lung cancer
por: Weng, Jinsen, et al.
Publicado: (2021)

Comprehensive T cell repertoire characterization of non-small cell lung cancer
por: Reuben, Alexandre, et al.
Publicado: (2020)

Response to crizotinib in a squamous cell lung carcinoma patient harbouring echinoderm microtubule‐associated protein‐like 4‐anaplastic lymphoma translocation: A case report
por: Wang, Wenxian, et al.
Publicado: (2015)

Combination of neutrophil-to-lymphocyte ratio and albumin concentration to predict the prognosis of esophageal squamous cell cancer patients undergoing esophagectomy
por: Lin, Shaofeng, et al.
Publicado: (2023)

Peripheral T-cell receptor repertoire dynamics in small cell lung cancer
por: Balbach, Meridith L., et al.
Publicado: (2023)

Treatment and prognosis after progression in long-term responders to EGFR-tyrosine kinase inhibitor in advanced non-small cell lung cancer
por: Song, Zhengbo, et al.
Publicado: (2016)

Bone marrow expands the repertoire of functional T cells targeting tumor-associated antigens in patients with resectable non-small-cell lung cancer
por: Safi, Seyer, et al.
Publicado: (2019)

The Landscape and Prognosis Potential of the T-Cell Repertoire in Membranous Nephropathy
por: Zhang, Yu, et al.
Publicado: (2020)

Tumor necrosis factor-related apoptosis-inducing ligand modulates angiogenesis and apoptosis to inhibit non-small cell lung carcinoma tumor growth in mice
por: Chen, Yuanmei, et al.
Publicado: (2019)

Prognosis of recurrent non-small cell lung cancer following complete resection
por: SASAKI, HIDEFUMI, et al.
Publicado: (2014)

Comprehensive analysis of T cell receptor repertoire in patients with KRAS mutant non-small cell lung cancer
por: Wang, Yadong, et al.
Publicado: (2022)

Efficacy and safety of maintenance immune checkpoint inhibitors with or without pemetrexed in advanced non-squamous non-small cell lung cancer: a retrospective study
por: Gu, Xiaodong, et al.
Publicado: (2022)

Antibody Repertoire in Paraneoplastic Cerebellar Degeneration and Small Cell Lung Cancer
por: Sabater, Lidia, et al.
Publicado: (2013)

Loss of expression rather than cytoplasmic mislocalization of RUNX3 predicts worse outcome in non-small cell lung cancer
por: Chen, Xiaohui, et al.
Publicado: (2018)

Prognosis of limited-stage small cell lung cancer with comprehensive treatment including radical resection
por: Zhong, Lili, et al.
Publicado: (2020)

Small Cell Size Circulating Aneuploid Cells as a Biomarker of Prognosis in Resectable Non-Small Cell Lung Cancer
por: Hong, Yang, et al.
Publicado: (2021)

PD-L1 Predicts Poor Prognosis in Surgically Resected Limited Stage Small-Cell Lung Cancer
por: Fu, Xiao, et al.
Publicado: (2020)

Multi-Region Genomic Landscape Analysis for the Preoperative Prediction of Lymph Node Metastasis in Esophageal Carcinoma
por: Lin, Shaofeng, et al.
Publicado: (2022)

Peripheral Tumor Location Predicts a Favorable Prognosis in Patients with Resected Small Cell Lung Cancer
por: Gao, Yina, et al.
Publicado: (2022)

The efficacy and safety of anlotinib treatment for advanced lung cancer
por: Shao, Lan, et al.
Publicado: (2019)

Deep immune B and plasma cell repertoire in non-small cell lung cancer
por: Patel, Akshay J., et al.
Publicado: (2023)

Prognosis of resected non-small cell lung cancer with pleural plaques on intrathoracic findings
por: Kagimoto, Atsushi, et al.
Publicado: (2022)

Distinct mutational backgrounds and clonal architectures implicated prognostic discrepancies in small-cell carcinomas of the esophagus and lung
por: Song, Zhengbo, et al.
Publicado: (2021)

Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer
por: Wang, Wenxian, et al.
Publicado: (2020)

T-cell receptor repertoires as potential diagnostic markers for patients with COVID-19
por: Hou, Xianliang, et al.
Publicado: (2021)

Flot-2 Expression Correlates with EGFR Levels and Poor Prognosis in Surgically Resected Non-Small Cell Lung Cancer
por: Wen, Qiuyuan, et al.
Publicado: (2015)

Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer
por: Chen, Ming, et al.
Publicado: (2021)

Efficacy of immune checkpoint inhibitors in patients with KRAS-mutant advanced non-small cell lung cancer: A retrospective analysis
por: Gu, Xiaodong, et al.
Publicado: (2023)

The prognosis of small-sized non-small cell lung cancer with visceral pleural invasion after sublobar resection
por: Choi, Si Young, et al.
Publicado: (2020)

Prognosis of Recurrence after Complete Resection in Early-Stage Non-Small Cell Lung Cancer
por: Choi, Pil Jo, et al.
Publicado: (2013)

Neoadjuvant immunochemotherapy with pembrolizumab plus chemotherapy in resectable non-small cell lung cancer
por: Chen, Yulong, et al.
Publicado: (2023)

T cell receptor repertoire profiling predicts the prognosis of HBV‐associated hepatocellular carcinoma
por: Lin, Kai‐Rong, et al.
Publicado: (2018)

Extent of Visceral Pleural Invasion Affects Prognosis of Resected Non-small Cell Lung Cancer: A meta-analysis
por: Wang, Ting, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ncbiq9g40i07805tgkmig5h51d